Correction: SAVI: molecular mechanisms, clinical spectrum and precision medicine approaches beyond type-I IFN
[This corrects the article DOI: 10.3389/fimmu.2026.1928419.].
We have 3 of 192 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
[This corrects the article DOI: 10.3389/fimmu.2026.1928419.].
BACKGROUND Anakinra is effective in recurrent pericarditis, yet optimal treatment duration and strategies for safe drug discontinuation remain uncertain. Identifying predictors of sustained remission after discontinuation is important for clinical management. METHODS We retrospectively analyzed 185 consecutive adult...
The transition from immune - to a mutational-perspective, provides a foundational framework to optimize diagnostic and therapeutic strategies for precision medicine in SAVI patients.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.